| ID | CAS | Name | Synonyms | Molecular Formula | Category |
|---|---|---|---|---|---|
| 1 | 22230-04-2 | dl-PGE2 | dl-PGE2 Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11α,13E,15S)-(+-)- 5-Heptenoic acid, 7-[3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-, (+-)- (8CI) | ||
| 2 | 65085-69-0 | ent-PGE2 | ent-PGE2 ent-Prostaglandin E2 XEYBRNLFEZDVAW-OBUVHCMGSA-N Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,8β,11β,12α,13E,15R)- | ||
| 3 | 86992-41-8 | LAPIFERINE | LAPIFERINE 2-Butenoic acid, 2-methyl-, (1aS,2S,2aS,5R,5aS,6S,7aR)-decahydro-2,5-dihydroxy-2a,7a-dimethyl-5-(1-methylethyl)azuleno[5,6-b]oxiren-6-yl ester, (2Z)- | ||
| 4 | 103301-70-8 | trioxilin A4 | trioxilin A4 | ||
| 5 | 1622429-53-1 | Lipoxin A4-d5 | Lipoxin A4-d5 IXAQOQZEOGMIQS-YUMLLTTFSA-N Lipoxin A4-d5 MaxSpecStandard | ||
| 6 | 104169-51-9 | Neorustmicin C | Neorustmicin C 4,5,10,11-Tetradehydro-6-demethyl-9-deoxo-5,6,11,12-tetradeoxy-9-hydroxy-6-oxoerythronolide A | ||
| 7 | 89663-86-5 | 5S,6R-LipoxinA4 | 5S,6R-LipoxinA4 | ||
| 8 | 363-24-6 | Prostaglandin E2 | PGE2 l-pge2 prostin dinoproston Dinoprostone DINOPROSTONE l-5-heptenoicaci Prostaglandin E2 l-prostaglandine2 (5E,13E)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate (11alpha,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (5Z,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oate Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,8ξ,12ξ,13E)- (5Z,11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoicaci Prosta-5,13-diene-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,11a,13E15S)- 7-[3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-5-heptenoic acid l-7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoicacid | ||
| 9 | 98049-69-5 | Lipoxin B4 (LXB4) | Lipoxin B4 Lipoxin B4 (LXB4) | ||
| 10 | 745-64-2 | PROSTAGLANDIN F3ALPHA | PGF3α Prostaglandin F3α PROSTAGLANDIN F3ALPHA 9ALPHA,11ALPHA,15S-TRIHYDROXY-PROSTA-5Z,13E,17Z-TRIEN-1-OIC ACID (5Z,13E,15S,17Z)-9α,11α,15-Trihydroxyprosta-5,13,17-trien-1-oic acid (5Z,9S,11R,13E,15S,17Z)-9,11,15-Trihydroxy-5,13,17-prostatriene-1-oic acid Prosta-5,13,17-trien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9α,11α,13E,15S,17Z)- (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dienyl]cyclopentyl]hept-5-enoic acid | ||
| 11 | 27415-25-4 | 8-ISO PROSTAGLANDIN E2 | 8-ISO PROSTAGLANDIN E2 Dinoprostone EP Impurity B XEYBRNLFEZDVAW-CLQOMRTCSA-N 8-iso Prostaglandin E2 Exclusive 9-OXO-11ALPHA,15S-DIHYDROXY-(8BETA)-PROSTA-5Z,13E-DIEN-1-OIC ACID Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,8β,11α,13E,15S)- (Z)-7-[(1S,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid | ||
| 12 | 38310-90-6 | 11BETA-PROSTAGLANDIN E2 | 11-epi-PGE2 11β-Prostaglandin E2 11BETA-PROSTAGLANDIN E2 11-epi-Prostaglandin E2 XEYBRNLFEZDVAW-YUOXZBOXSA-N 9-OXO-11BETA,15S-DIHYDROXY-PROSTA-5Z,13E-DIEN-1-OIC ACID (5Z,13E,15S)-9-Oxo-11β,15-dihydroxyprosta-5,13-diene-1-oic acid (5Z,13E,15S)-11β,15-Dihydroxy-9-oxo-5,13-prostadiene-1-oic acid (5Z,11S,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid | ||
| 13 | 35850-13-6 | 15-ketoprostaglandin F2A | 15-ketoprostaglandin F2A 15-Ketoprostaglandinef2alpha 15-oxo-prostaglandin F2alpha 15-KETO PROSTAGLANDIN F2ALPHA 15-keto Prostaglandin F2 MaxSpecStandard 15-keto Prostaglandin F2α Lipid Maps MS Standard 9,11-Dihydroxy-15-oxo-[5Z,9α,11α,13E]-prosta-5,13-dien-1-oic acid (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E)-3-oxooct-1-enyl]cyclopentyl]hept-5-enoic acid | ||
| 14 | 42935-17-1 | Prostaglandin H2 Solution | Prostaglandin H2 Solution | ||
| 15 | 211100-24-2 | 17-trans Prostaglandin F3α | 17-trans Prostaglandin F3α SAKGBZWJAIABSY-XYJRQBLTSA-N Prosta-5,13,17-trien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9α,11α,13E,15S,17E)- (9CI) | ||
| 16 | 84807-93-2 | PGE2, [5,6,8,11,12,14,15-3H] | PGE2, [5,6,8,11,12,14,15-3H] PROSTAGLANDIN E2, [5,6,8,11,12,14,15-3H] PROSTAGLANDIN E2-[5,6,8,11,12,14,15-3H(N)] [5,6,8,11,12,14,15(N)-3H]-PROSTAGLANDIN E2 | ||
| 17 | 17-TRANS PROSTAGLANDIN F3ALPHA | 17-TRANS PROSTAGLANDIN F3ALPHA 9ALPHA,11ALPHA,15S-TRIHYDROXY-PROSTA-5Z,13E,17E-TRIEN-1-OIC ACID | |||
| 18 | 869384-82-7 | 14-Deoxy-17-hydroxyandrographolide | 14-DEOXY-17-HYDROXYANDROGRAPHOLI 14-Deoxy-17-hydroxyandrographolide 2(5H)-Furanone, 3-[2-[(1R,2S,4aS,5R,6R,8aS)-decahydro-6-hydroxy-2,5-bis(hydroxymethyl)-5,8a-dimethyl-1-naphthalenyl]ethyl]- | ||
| 19 | 59894-05-2 | 15(R)-Prostaglandin D2 (15(R)-PGD2) | 15(R)-Prostaglandin D2 15(R)-Prostaglandin D2 (15(R)-PGD2) | ||
| 20 | 59894-07-4 | 13,14-DIHYDRO-15-KETO PROSTAGLANDIN D2 | 13,14-DIHYDRO-15-KETO PROSTAGLANDIN D2 | ||
| 21 | 142750-40-1 | 4,6,8-trihydroxy-11-capnosene-2,10-dione | 4,6,8-trihydroxy-11-capnosene-2,10-dione | ||
| 22 | 308821-59-2 | Kauran-18-olcacid,16,1719-tnhydroxy-,(4a) | Kauran-18-olcacid,16,1719-tnhydroxy-,(4a) Kauran-18-olc acid,16,1719-tnhydroxy-,(4a) (4alpha)-16,17,19-Trihydroxykauran-18-oic acid Kauran-18-oic acid, 16,17,19-trihydroxy-, (4α)- Ent-16a, 17,19-trihydroxy chitosan-18-carboxylic acid (10alpha)-16alpha,17,19-Trihydroxykaurane-18-oic acid | ||
| 23 | 142543-30-4 | ent-13,16β,17-Trihydroxykauran-19-oic acid | ent-13,16β,17-Trihydroxykauran-19-oic acid Kauran-18-oic acid, 13,16,17-trihydroxy-, (4α)- | ||
| 24 | 63558-38-3 | (16R)-9β,16,17-Trihydroxykauran-18-oic acid | Cofarol (16R)-9β,16,17-Trihydroxykauran-18-oic acid Kauran-18-oic acid, 9,16,17-trihydroxy-, (4α)- | ||
| 25 | 69413-73-6 | 9,11-DIOXO-15S-HYDROXY-PROST-13E-EN-1-OIC ACID | PROSTAGLANDIN K1 KJWZYMMLVHIVSU-IYCNHOCDSA-N 9,11-DIOXO-15S-HYDROXY-PROST-13E-EN-1-OIC ACID | ||
| 26 | 106402-09-9 | 3-oxa-9(O)-methano-delta(6,9)prostaglandin I(1) | 3-oxa-9(O)-methano-delta(6,9)prostaglandin I(1) Acetic acid, 2-[2-[(3aS,4R,5R,6aS)-3,3a,4,5,6,6a-hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-1-octen-1-yl]-2-pentalenyl]ethoxy]- | ||
| 27 | 5,6,15-trihydroxy-7,9,11,13-eicosatetraenoic acid | 5,6,15-trihydroxy-7,9,11,13-eicosatetraenoic acid | |||
| 28 | 79008-24-5 | 5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid | 5,12,20-trihydroxy-6,8,10,14-eicosatetraenoic acid 6,8,10,14-Eicosatetraenoic acid, 5,12,20-trihydroxy-, [S-[R*,R*-(E,E,Z,Z)]]- (9CI) | ||
| 29 | 98004-40-1 | 10,11,12-trihydroxy-5,8,14,17-eicosatetraenoic acid | 10,11,12-trihydroxyicosa-5,8,14,17-tetraenoic acid 10,11,12-trihydroxy-5,8,14,17-eicosatetraenoic acid | ||
| 30 | 17-hydroxy-17-methyl-2,3-secoandrostane-2,3-dioic acid | 17-hydroxy-17-methyl-2,3-secoandrostane-2,3-dioic acid | |||
| 31 | 155680-06-1 | 2H-Cyclopenta[b]furan, prosta-5,13-dien-1-oic acid deriv. | 2H-Cyclopenta[b]furan, prosta-5,13-dien-1-oic acid deriv. Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, (5Z,9α,11α,13E,15S)-(+-)- Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, (5Z,9α,11α,13E,15S)-(±)- (9CI) | ||
| 32 | 7-[3-hydroxy-5-oxo-2-(3-oxooct-1-enyl)cyclopentyl]heptanoic acid | (13E)-11a-Hydroxy-9,15-dioxoprost-13-enoic acid 7-[3-hydroxy-5-oxo-2-(3-oxooct-1-enyl)cyclopentyl]heptanoic acid | |||
| 33 | 79516-82-8 | (5S,12R)-5,12,20-TRIHYDROXY-(6Z,8E,10E,14Z)-EICOSATETRAENOIC ACID | (5S,12R)-5,12,20-TRIHYDROXY-(6Z,8E,10E,14Z)-EICOSATETRAENOIC ACID | ||
| 34 | 58185-89-0 | 10-(2-Hydroxy-3,4-dimethoxy-6-methylphenyl)decanoic acid methyl ester | 10-(2-Hydroxy-3,4-dimethoxy-6-methylphenyl)decanoic acid methyl ester Benzenedecanoic acid, 2-hydroxy-3,4-dimethoxy-6-methyl-, methyl ester | ||
| 35 | 28977-23-3 | (5Z,13E,15S,17Z)-9β,11α,15-Trihydroxyprosta-5,13,17-trien-1-oic acid | PGGF3β Prostaglandin GF3β (5Z,13E,15S,17Z)-9β,11α,15-Trihydroxyprosta-5,13,17-trien-1-oic acid | ||
| 36 | 171030-11-8 | (5S,6R,15R)-5,6,15-TRIHYDROXY-7,9,13-TRANS-11-CIS-EICOSATETRAENOIC ACID | 15(R)-LXA4 LXA4-15-EPI 15(R)-Lipoxin A4 LIPOXIN A4, 15-EPI ASPIRIN-TRIGGERED LXA4 5(S),6(R),15(R)-Lipoxin A4 IXAQOQZEOGMIQS-JEWNPAEBSA-N (5S,6R,15R)-5,6,15-TRIHYDROXY-7,9,13-TRANS-11-CIS-EICOSATETRAENOIC ACID | ||
| 37 | 91712-41-3 | (5Z,8R,9R,10E,12S)-8-acetyl-9-formyl-12-hydroxyheptadeca-5,10-dienoic acid | LGE2 Levuglandin E2 levuglandin LGD2 (5Z,8R,9R,10E,12S)-8-Acetyl-12-hydroxy-9-formyl-5,10-heptadecadienoic acid (5Z,8R,9R,10E,12S)-8-acetyl-9-formyl-12-hydroxyheptadeca-5,10-dienoic acid | ||
| 38 | 57576-52-0 | 7-[3-(3-hydroxyoct-1-enyl)-4,6-dioxabicyclo[3.1.1]hept-2-yl]hept-5-enoic acid | TXA2 Rabbit aorta contracting substance (5Z,13E,15S)-9α,11α-Epoxy-15-hydroxythromboxa-5,13-dien-1-oic acid 7-[3-(3-hydroxyoct-1-enyl)-4,6-dioxabicyclo[3.1.1]hept-2-yl]hept-5-enoic acid (Z)-7-[(1S,2S,3R,5S)-3-[(E,3S)-3-hydroxyoct-1-enyl]-4,6-dioxabicyclo[3.1.1]heptan-2-yl]hept-5-enoic acid 5-Heptenoic acid, 7-[(1S,3R,4S,5S)-3-[(1E,3S)-3-hydroxy-1-octen-1-yl]-2,6-dioxabicyclo[3.1.1]hept-4-yl]-, (5Z)- | ||
| 39 | 65870-86-2 | Prosta-6,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, (9α,11α,13E,15S)- (9CI) | ProstacyclinImpurity1 Prosta-6,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, (9α,11α,13E,15S)- (9CI) | ||
| 40 | 191919-01-4 | (Z)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(E)-3-oxooct-1-enyl]cyclopentyl]hept-5-enoic acid | 8-iso-15-keto-PGF2alpha LOLJEILMPWPILA-RLXHZABYSA-N 8-iso-15-keto Prostaglandin F2α (Z)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(E)-3-oxooct-1-enyl]cyclopentyl]hept-5-enoic acid | ||
| 41 | 136845-33-5 | D-allo-Nonitol, 1,2,3,6-tetradeoxy-5-O-methyl-8,9-O-(1-methylethylidene)-7-O-(phenylmethyl)- | D-allo-Nonitol, 1,2,3,6-tetradeoxy-5-O-methyl-8,9-O-(1-methylethylidene)-7-O-(phenylmethyl)- | ||
| 42 | 136759-78-9 | D-altro-Nonitol, 1,2,3,6-tetradeoxy-5-O-methyl-8,9-O-(1-methylethylidene)-7-O-(phenylmethyl)- | D-altro-Nonitol, 1,2,3,6-tetradeoxy-5-O-methyl-8,9-O-(1-methylethylidene)-7-O-(phenylmethyl)- D-altro-Nonitol, 1,2,3,6-tetradeoxy-5-O-methyl-8,9-O-(1-methylethylidene)-7-O-(phenylmethyl)- (9CI) | ||
| 43 | 136781-78-7 | D-allo-Octitol, 1,2,5-trideoxy-2-methyl-4-O-methyl-7,8-O-(1-methylethylidene)-6-O-(phenylmethyl)- | D-allo-Octitol, 1,2,5-trideoxy-2-methyl-4-O-methyl-7,8-O-(1-methylethylidene)-6-O-(phenylmethyl)- | ||
| 44 | 136759-79-0 | D-altro-Octitol, 1,2,5-trideoxy-2-methyl-4-O-methyl-7,8-O-(1-methylethylidene)-6-O-(phenylmethyl)- | D-altro-Octitol, 1,2,5-trideoxy-2-methyl-4-O-methyl-7,8-O-(1-methylethylidene)-6-O-(phenylmethyl)- D-altro-Octitol, 1,2,5-trideoxy-2-methyl-4-O-methyl-7,8-O-(1-methylethylidene)-6-O-(phenylmethyl)- (9CI) | ||
| 45 | 7045-31-0 | (Z)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dienyl]cyclopentyl]hept-5-enoic acid | 8-epi PGF3α 8-iso-PGF3alpha 8-iso Prostaglandin F3α 8-ISO PROSTAGLANDIN F3Α SAKGBZWJAIABSY-PJCXKLBTSA-N 8-iso Prostaglandin F3α Exclusive Prosta-5,13,17-trien-1-oic acid, 9,11,15-trihydroxy-, (5Z,8β,9α,11α,13E,15S,17Z)- (Z)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dienyl]cyclopentyl]hept-5-enoic acid | ||
| 46 | (1S,5R,6R,7R)-6-[(1E,3S)-3-Hydroxy-1-octenyl]-7-(tetrahydro-2H-pyran-2-yloxy)-2-oxabicyclo[3.3.0]octan-3-one | (1S,5R,6R,7R)-6-[(1E,3S)-3-Hydroxy-1-octenyl]-7-(tetrahydro-2H-pyran-2-yloxy)-2-oxabicyclo[3.3.0]octan-3-one | |||
| 47 | 107484-63-9 | 1,2-Dioxin-3-acetic acid, 6-(8,10-dodecadienyl)-3,6-dihydro-6-methoxy- , methyl ester, [3alpha,6alpha,6(8E,10E)]- | methyl (3S*,6S*,14E,16E)-3,6-epidioxy-6-methoxyoctadeca-4,14,16-trienoate 1,2-Dioxin-3-acetic acid, 6-(8,10-dodecadienyl)-3,6-dihydro-6-methoxy- , methyl ester, [3alpha,6alpha,6(8E,10E)]- | ||
| 48 | 91284-06-9 | 5-((2R,3aR,4R,5R,6aS)-4-((S,E)-3-Hydroxyoct-1-en-1-yl)hexahydro-2H-2,5-epoxycyclopenta[b]furan-2-yl)pentanoic acid | ProstacyclinImpurity2 5-((2R,3aR,4R,5R,6aS)-4-((S,E)-3-Hydroxyoct-1-en-1-yl)hexahydro-2H-2,5-epoxycyclopenta[b]furan-2-yl)pentanoic acid | ||
| 49 | 67884-42-8 | 2,3,3a,6,7,7a-Hexahydro-3a-hydroxy-β,7a-dimethyl-1-[(tetrahydro-2H-pyran-2-yl)oxy]-1H-indene-5-propanoic acid methyl ester | 2,3,3a,6,7,7a-Hexahydro-3a-hydroxy-β,7a-dimethyl-1-[(tetrahydro-2H-pyran-2-yl)oxy]-1H-indene-5-propanoic acid methyl ester 1H-Indene-5-propanoic acid, 2,3,3a,6,7,7a-hexahydro-3a-hydroxy-β,7a-dimethyl-1-[(tetrahydro-2H-pyran-2-yl)oxy]-, methyl ester | ||
| 50 | 38302-26-0 | (2S,10aα,11aα,12R)-Tetradecahydro-3,3,7-trimethyl-11-methylene-5aβ,8β-methano-5aH-cyclohepta[b]naphthalene-2α,4α,4aβ,7β,12-pentol | Leucothol B (2S,10aα,11aα,12R)-Tetradecahydro-3,3,7-trimethyl-11-methylene-5aβ,8β-methano-5aH-cyclohepta[b]naphthalene-2α,4α,4aβ,7β,12-pentol 5a,8-Methano-5aH-cyclohepta[b]naphthalene-2,4,4a,7,12(5H)-pentol, dodecahydro-3,3,7-trimethyl-11-methylene-, [2S-(2α,4α,4aβ,5aβ,7β,8β,10aα,11aα,12S*)]- (9CI) | ||
| 51 | 80865-69-6 | (2S,5S)-3'aα,4,4',5,5',6',7',7'a-Octahydro-4',4',5,7'aβ-tetramethyl-3'α-(2-oxopropyl)spiro[furan-2(3H),1'(3'H)-isobenzofuran]-5-acetic acid | Chrysothame (2S,5S)-3'aα,4,4',5,5',6',7',7'a-Octahydro-4',4',5,7'aβ-tetramethyl-3'α-(2-oxopropyl)spiro[furan-2(3H),1'(3'H)-isobenzofuran]-5-acetic acid | ||
| 52 | 90578-10-2 | (4aS)-5-[(R)-2-[(S)-2-[(S)-1,2-Dihydroxyethyl]oxiranyl]-2-hydroxyethyl]-3,4,4aα,5,6,7,8,8a-octahydro-5β,6α,8aβ-trimethyl-1-naphthalenecarbaldehyde | PR-1421 Tetrahydroclerocidin (4aS)-5-[(R)-2-[(S)-2-[(S)-1,2-Dihydroxyethyl]oxiranyl]-2-hydroxyethyl]-3,4,4aα,5,6,7,8,8a-octahydro-5β,6α,8aβ-trimethyl-1-naphthalenecarbaldehyde (4aS)-5α-[(2R)-2-[(2S)-2-[(1S)-1,2-Dihydroxyethyl]oxiranyl]-2-hydroxyethyl]-3,4,4aα,5,6α,7,8,8a-octahydro-5β,6α,8aβ-trimethyl-1-naphthalenecarbaldehyde | ||
| 53 | 98263-93-5 | [3S,6aβ,(+)]-3,4,5,6,6a,7,8,9-Octahydro-7-[(Z)-5-hydroxy-3-hydroxymethyl-3-pentenyl]-7α-hydroxymethyl-3,8α-dimethyl-3α,9aα-methano-1H-cyclopenta[c]oxocin-1-one | Portulic lactone (+)-Portulic lactone [3S,6aβ,(+)]-3,4,5,6,6a,7,8,9-Octahydro-7-[(Z)-5-hydroxy-3-hydroxymethyl-3-pentenyl]-7α-hydroxymethyl-3,8α-dimethyl-3α,9aα-methano-1H-cyclopent[c]oxocin-1-one [3S,6aβ,(+)]-3,4,5,6,6a,7,8,9-Octahydro-7-[(Z)-5-hydroxy-3-hydroxymethyl-3-pentenyl]-7α-hydroxymethyl-3,8α-dimethyl-3α,9aα-methano-1H-cyclopenta[c]oxocin-1-one | ||
| 54 | 77353-84-5 | (2S,4aα,5aα,8aα,8bα)-3,4,4a,5,5a,6,7,8,8a,8b-Decahydro-3α-[(S)-2-hydroxy-1-methylethyl]-2aα,5,8-trimethyl-2,5β-methano-2H-s-indaceno[8,1-bc]furan-2,8α,8cα-triol | (2S,4aα,5aα,8aα,8bα)-3,4,4a,5,5a,6,7,8,8a,8b-Decahydro-3α-[(S)-2-hydroxy-1-methylethyl]-2aα,5,8-trimethyl-2,5β-methano-2H-s-indaceno[8,1-bc]furan-2,8α,8cα-triol |
| ID | CAS | Product Name | Suppliers | Descriptions |
|---|